Meet Elena "Ella" Sinclair

Elena "Ella" Sinclair is the founder and principal consultant of FlexPoint Bio, a consulting firm specializing in clinical program and project management, biomarker and biospecimen strategy, risk-based quality management, clinical outsourcing, and operational readiness for emerging biotech companies.

​

Ella brings over 20 years of experience spanning bench research, site-level clinical operations, and sponsor-side trial execution. She has led complex early-to-pivotal phase programs end-to-end — from project-level study execution and cross-functional program coordination to vendor oversight, inspection readiness, and building the SOPs and scalable frameworks that become a clinical team's operational backbone. She holds an MBA with a specialization in Data Analysis and Project Management and an advanced degree in life sciences.

​

That depth of experience is what drives FlexPoint Bio's approach. Ella founded the firm because she witnessed firsthand how strategic clarity, disciplined project execution, and strong program governance can accelerate a program's success — and how the absence of any one of them can quietly derail it. Passionate about ethical and innovative AI implementation, she is focused on driving lean, technology-forward clinical trials where AI-powered tools enhance decision-making, streamline monitoring, and reduce operational burden without compromising quality or compliance.

​

Today, she and her collaborators partner with biotech founders, CEOs, and clinical leaders to provide fractional program and project management leadership — helping lean teams build inspection-ready programs that deliver treatments to patients faster, safer, and more reliably. For Ella, helping startups bridge the gap between vision and execution is both a responsibility and a privilege.

​